Does OMALIZUMAB Cause Gait inability? 219 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 219 reports of Gait inability have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.3% of all adverse event reports for OMALIZUMAB.
219
Reports of Gait inability with OMALIZUMAB
0.3%
of all OMALIZUMAB reports
20
Deaths
139
Hospitalizations
How Dangerous Is Gait inability From OMALIZUMAB?
Of the 219 reports, 20 (9.1%) resulted in death, 139 (63.5%) required hospitalization, and 21 (9.6%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OMALIZUMAB. However, 219 reports have been filed with the FAERS database.
What Other Side Effects Does OMALIZUMAB Cause?
No adverse event (9,736)
Asthma (9,354)
Urticaria (9,231)
Off label use (9,199)
Dyspnoea (8,323)
Drug ineffective (6,747)
Cough (5,926)
Pruritus (5,224)
Fatigue (5,053)
Malaise (4,820)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which OMALIZUMAB Alternatives Have Lower Gait inability Risk?
OMALIZUMAB vs OMAVELOXOLONE
OMALIZUMAB vs OMBITASVIR
OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS
OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS